Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (901-910 of 982) with videos related to

Pageof 99
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation CarriersAlexandra J van den Broek, Laura J van 't Veer, Maartje J Hooning, et al.
Scientific Reports|February 3, 2015
Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposureCorinna Glasner, Mirjan M van Timmeren, Tim Stobernack, et al.
The New England Journal of Medicine|July 30, 2004
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL TrialsIris Noordhoek, Erik J Blok, Elma Meershoek-Klein Kranenbarg, et al.
The New England Journal of Medicine|December 20, 2002
A gene-expression signature as a predictor of survival in breast cancerMarc J van de Vijver, Yudong D He, Laura J van't Veer, et al.
Journal of Autoimmunity|November 6, 2023
Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitisAna Merino-Vico, Jan Piet van Hamburg, Paul Tuijnenburg, et al.
Physics and Imaging in Radiation Oncology|November 24, 2025
Towards clinical implementation of T2-weighted cine imaging for intrafraction drift correction workflows on the 1.5 Tesla magnetic resonance-linear acceleratorLieke T C Meijers, Johannes C J de Boer, Jochem R M van de Voort van Zyp, et al.
Journal of Clinical Immunology|June 5, 2023
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 CohortMarie Valérie E Andriessen, G Elizabeth Legger, Robbert G M Bredius, et al.
Stroke|May 22, 2025
Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN TrialAnke Wouters, Jelle Demeestere, Jean-Benoît Rossel, et al.
British Journal of Cancer|April 3, 1999
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2M J Ligtenberg, F B Hogervorst, H W Willems, et al.
Pageof 99

Showing results (901-910 of 982) with videos related to

Sort By:
Pageof 99
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation CarriersAlexandra J van den Broek, Laura J van 't Veer, Maartje J Hooning, et al.
Scientific Reports|February 3, 2015
Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposureCorinna Glasner, Mirjan M van Timmeren, Tim Stobernack, et al.
The New England Journal of Medicine|July 30, 2004
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predispositionMieke Kriege, Cecile T M Brekelmans, Carla Boetes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 25, 2020
Overestimation of Late Distant Recurrences in High-Risk Patients With ER-Positive Breast Cancer: Validity and Accuracy of the CTS5 Risk Score in the TEAM and IDEAL TrialsIris Noordhoek, Erik J Blok, Elma Meershoek-Klein Kranenbarg, et al.
The New England Journal of Medicine|December 20, 2002
A gene-expression signature as a predictor of survival in breast cancerMarc J van de Vijver, Yudong D He, Laura J van't Veer, et al.
Journal of Autoimmunity|November 6, 2023
Targeting NF-κB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitisAna Merino-Vico, Jan Piet van Hamburg, Paul Tuijnenburg, et al.
Physics and Imaging in Radiation Oncology|November 24, 2025
Towards clinical implementation of T2-weighted cine imaging for intrafraction drift correction workflows on the 1.5 Tesla magnetic resonance-linear acceleratorLieke T C Meijers, Johannes C J de Boer, Jochem R M van de Voort van Zyp, et al.
Journal of Clinical Immunology|June 5, 2023
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 CohortMarie Valérie E Andriessen, G Elizabeth Legger, Robbert G M Bredius, et al.
Stroke|May 22, 2025
Prior Reperfusion Strategy Does Not Modify Outcome in Early Versus Late Start of Anticoagulants in Patients With Ischemic Stroke: Prespecified Subanalysis of the Randomized Controlled ELAN TrialAnke Wouters, Jelle Demeestere, Jean-Benoît Rossel, et al.
British Journal of Cancer|April 3, 1999
Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2M J Ligtenberg, F B Hogervorst, H W Willems, et al.
Pageof 99